Buy & Sell Summit Therapeutics Inc (SMMT) – Summit Therapeutics Inc Price Today
Key Stats
- $13.51BMarket Cap
- HealthSector
- -39.92%3M Drawdown
- $12.93BEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 7 daysTypical Hold Time
Summit Therapeutics Inc (SMMT) is currently valued at a market capitalization of $13.51B, with an enterprise value of $12.93B. Over the past 52 weeks, Summit Therapeutics Inc has traded between a low of $13.85 and a high of $29.32, highlighting its annual price range. Over the past three months, Summit Therapeutics Inc has recorded a drawdown of -39.92%, reflecting recent price volatility. On average, investors hold Summit Therapeutics Inc for approximately 7 days, indicating typical investor behavior on the platform.
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Most Recent News
Aduro Clean Technologies to present at key investor and industry conferences in June 2026
Aduro Clean Technologies announced its participation in several investor and industry conferences in June 2026, including events in London, Toronto, Frankfurt, and Pittsburgh. The company will showcase its Hydrochemolytic™ technology, discuss progres...

Aduro Clean Technologies to present at key industry and investor conferences in June 2026.
Aduro Clean Technologies announced its participation in several major industry and investor conferences in June 2026, including events in London, Toronto, Frankfurt, and Pittsburgh. The company will showcase its Hydrochemolytic™ Technology and discus...

ZenaTech targets US Defense Dept. investments to expand AI drone production and national security tech.
ZenaTech Inc., a tech company specializing in AI-powered drones, announced plans to seek investment opportunities with the US Department of Defense and the Office of Strategic Capital. This move follows reports of the US government engaging with dome...
